Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer

Rolf Gedeborga Department of Surgical Sciences, Uppsala University, Uppsala, SwedenCorrespondence[email protected]

https://orcid.org/0000-0002-8850-7863 View further author information

Lars Lindhagenb Uppsala Clinical Research Center (UCR), Uppsala, SwedenView further author information

Stacy Loebc Department of Urology and Population Health, New York University and Manhattan Veterans Affairs Medical Center, New York, NY, USA;View further author information

Johan Styrked Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, SwedenView further author information

Hans Garmoa Department of Surgical Sciences, Uppsala University, Uppsala, Sweden;e Translational Oncology and Urology Research (TOUR), King's College London, Guy's Hospital, London, UKView further author information

Pär Stattina Department of Surgical Sciences, Uppsala University, Uppsala, SwedenView further author information

Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date